KEAP1 and early-onset autosomal dominant Alzheimer disease: Extensive research on Nrf2–Keap1 signaling has been performed to elucidate the roles of this PPI in various diseases caused by oxidative stress, including cancer, Alzheimer’s disease (AD), chronic kidney disease, and diabetes.